Hanamura T, Aoki H
Research and Development Div., Nichirei Foods, Inc., 9 Shinminato, Mihama-ku, Chiba-shi, Chiba 261-8545, Japan.
J Food Sci. 2008 May;73(4):T55-61. doi: 10.1111/j.1750-3841.2008.00708.x.
Acerola (Malpighia emarginata DC.) is known to be one of the best fruits rich in ascorbic acid and polyphenols. Acerola polyphenols (APs) were found to have radical scavenging activities and inhibitory effects on both alpha-glucosidase and advanced glycation endproducts (AGEs) production. While polyphenols from several foodstuffs have been shown to be safe, APs, which differ from those of other foodstuffs, have not been evaluated for their toxicological properties. Here, we report preliminary toxicological and safety evaluations of crude APs (C-AP), which were obtained by eluting an XAD7HP column-adsorbed fraction of APs with 70% ethanol containing malic acid. The total polyphenol content of C-AP was 57.7% with the main polyphenols being proanthocyanidin and cyanidin-3-alpha-O-rhamnoside. For toxicological evaluations, C-AP was administered orally to rats at doses of 2000 mg/kg body weight (acute) or 100, 300, and 1000 mg/kg body weight/d for 28 (subacute) and 90 (subchronic) d. In the acute oral toxicological test, no deaths or abnormalities at necropsy on day 14 were observed, confirming that the minimum fatal dose of C-AP is greater than 2000 mg/kg body weight. In both subacute and subchronic toxicological tests, no death was recorded and the body weights and food intakes of the rats did not differ significantly from the control groups. Besides, there were no abnormal clinical signs related to administration of C-AP in any of the experimental animals. These results provide an important reference for the safety of APs as a food supplement for human consumption.
针叶樱桃(Malpighia emarginata DC.)是已知富含抗坏血酸和多酚的最佳水果之一。已发现针叶樱桃多酚(APs)具有自由基清除活性以及对α-葡萄糖苷酶和晚期糖基化终产物(AGEs)生成的抑制作用。虽然几种食品中的多酚已被证明是安全的,但与其他食品不同的APs尚未进行毒理学特性评估。在此,我们报告了粗制APs(C-AP)的初步毒理学和安全性评估,C-AP是通过用含苹果酸的70%乙醇洗脱XAD7HP柱吸附的APs部分而获得的。C-AP的总多酚含量为57.7%,主要多酚为原花青素和矢车菊素-3-α-O-鼠李糖苷。为进行毒理学评估,以2000 mg/kg体重(急性)或100、300和1000 mg/kg体重/天的剂量给大鼠口服C-AP,持续28天(亚急性)和90天(亚慢性)。在急性经口毒理学试验中,在第14天尸检时未观察到死亡或异常,证实C-AP的最小致死剂量大于2000 mg/kg体重。在亚急性和亚慢性毒理学试验中,均未记录到死亡,大鼠的体重和食物摄入量与对照组无显著差异。此外,任何实验动物均未出现与给予C-AP相关的异常临床体征。这些结果为APs作为人类食用的食品补充剂的安全性提供了重要参考。